# EDGAR Filing Document

**Accession Number:** 0000746598
**File Stem:** 0000746598-25-000059
**Filing Date:** 2025-11
**Character Count:** 51494
**Document Hash:** e75c49d0d167191a06d5a48729eced7d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000746598-25-000059.hdr.sgml**: 20251117

**ACCESSION NUMBER**: 0000746598-25-000059

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 32

**CONFORMED PERIOD OF REPORT**: 20251117

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251117

**DATE AS OF CHANGE**: 20251117

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BRADY CORP
- **CENTRAL INDEX KEY:** 0000746598
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS MANUFACTURING INDUSTRIES [3990]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 390178960
- **STATE OF INCORPORATION:** WI
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14959
- **FILM NUMBER:** 251489312

**BUSINESS ADDRESS:**
- **STREET 1:** 6555 W GOOD HOPE RD
- **STREET 2:** P O BOX 571
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53201-0571
- **BUSINESS PHONE:** 4143586600

**MAIL ADDRESS:**
- **STREET 1:** 6555 GOOD HOPE RD
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53223

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BRADY W H CO
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? brc-20251117

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

 

**FORM 8-K**

 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): November 17, 2025** 

 

**BRADY CORPORATION**

**(Exact name of registrant as specified in its charter)**

 

**Commission File Number 1-14959** 

---

| | |
|:---|:---|
| **Wisconsin** | **39-0178960** |
| **(State or other jurisdiction of incorporation or organization)** | **(IRS Employer Identification No.)** |

---

**6555 West Good Hope Road**

**Milwaukee, Wisconsin 53223**

**(Address of principal executive offices and Zip Code)**

**(414) 358-6600** 

**(Registrant's Telephone Number)**

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Class A Nonvoting Common Stock, par value $0.01 per share | BRC | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On November 17, 2025, Brady Corporation (the "Company") issued a press release announcing its fiscal 2026 first quarter financial results. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 attached hereto and is incorporated herein by reference.

Item 7.01 REGULATION FD DISCLOSURE

On November 17, 2025, the Company hosted a conference call related to its fiscal 2026 first quarter financial results. A copy of the slides referenced in the conference call, which is also posted on the Corporation's website, is being furnished to the Securities and Exchange Commission as Exhibit 99.2 attached hereto and is incorporated herein by reference.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

---

| | |
|:---|:---|
| EXHIBIT NUMBER | DESCRIPTION |
| 99.1 | <u>[Press Release of Brady Corporation, dated November 1](exhibit991pressrelease1031.htm)[7](exhibit991pressrelease1031.htm)[, 202](exhibit991pressrelease1031.htm)[5](exhibit991pressrelease1031.htm)[, relating to first quarter fiscal 202](exhibit991pressrelease1031.htm)[6](exhibit991pressrelease1031.htm)[financial results.](exhibit991pressrelease1031.htm)</u> |
| 99.2 | <u>[Informational slides provided by Brady Corporation, dated November 1](f26q1conferencecallprese.htm)[7](f26q1conferencecallprese.htm)[, 202](f26q1conferencecallprese.htm)[5](f26q1conferencecallprese.htm)[, relating to first quarter fiscal 202](f26q1conferencecallprese.htm)[6](f26q1conferencecallprese.htm)[financial results.](f26q1conferencecallprese.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within Inline XBRL document). |

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| | BRADY CORPORATION |
| Date: November 17, 2025 | |
| | /s/ ANN E. THORNTON |
| | Ann E. Thornton |
| | Chief Financial Officer, Chief Accounting Officer and Treasurer |

---

## Exhibit 99.1

**<u>EXHIBIT 99.1</u>**

<u>For More Information:</u>

Investor contact: Ann Thornton 414-438-6887

Media contact: Kate Venne 414-358-5176

**<u>Brady Corporation Reports Fiscal 2026 First Quarter Results and Raises the Low End of its Fiscal 2026 Adjusted Diluted EPS Guidance</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales for the quarter increased 7.5 percent. Organic sales increased 2.8 percent, acquisitions increased sales 3.2 percent, and foreign currency increased sales 1.5 percent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Diluted EPS increased 16.5 percent to $1.13 in the first quarter of fiscal 2026 compared to $0.97 in the same quarter of the prior year. Adjusted Diluted EPS\* increased 8.0 percent to $1.21 in the first quarter of fiscal 2026 compared to $1.12 in the same quarter of the prior year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash flow from operating activities increased 42.5 percent to $33.4 million in the first quarter of fiscal 2026 compared to $23.4 million in the same quarter of the prior year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The low end of Adjusted Diluted EPS\* guidance was raised for the full year ending July 31, 2026 from the previous range of $4.85 to $5.15 per share to the new range of $4.90 to $5.15 per share. GAAP earnings per diluted Class A Nonvoting Common share guidance for the full year ending July 31, 2026 was adjusted for acquisition-related amortization to $4.57 to $4.82 per share, from $4.55 to $4.85 per share.

MILWAUKEE (November 17, 2025) -- Brady Corporation (NYSE: BRC) ("Brady" or "Company"), a world leader in identification solutions, today reported its financial results for its fiscal 2026 first quarter ended October 31, 2025.

**Quarter Ended October 31, 2025 Financial Results:**

Sales for the quarter ended October 31, 2025 increased 7.5 percent, which consisted of an organic sales increase of 2.8 percent, an increase of 3.2 percent from acquisitions and an increase of 1.5 percent from foreign currency translation. Sales for the quarter ended October 31, 2025 were $405.3 million compared to $377.1 million in the same quarter last year. By region, sales increased 9.6 percent in the Americas & Asia and increased 3.6 percent in Europe & Australia, which included organic sales growth of 4.7 percent in the Americas & Asia and an organic sales decline of 0.8 percent in Europe & Australia.

Income before income taxes increased 16.5 percent to $68.5 million in the quarter ended October 31, 2025 compared to $58.8 million in the same quarter last year. Adjusted Income Before Income Taxes\* in the quarter ended October 31, 2025, which was adjusted for amortization expense of $5.3 million, was $73.8 million, an increase of 7.6 percent compared to the first quarter of last year. Adjusted Income Before Income Taxes\* in the quarter ended October 31, 2024, which was adjusted for amortization expense and other acquisition-related charges of $9.8 million, was $68.6 million.

Net income in the quarter ended October 31, 2025 was $53.9 million compared to $46.8 million in the same quarter last year. Earnings per diluted Class A Nonvoting Common Share was $1.13 in the first quarter of fiscal 2025 compared to $0.97 in the same quarter last year. Adjusted Net Income\* in the quarter ended October 31, 2025 was $58.0 million compared to $54.2 million in the same quarter last year. Adjusted Diluted EPS\* in the quarter ended October 31, 2025 was $1.21 compared to $1.12 in the same quarter last year.

------

**Commentary:**

"Our investments in research and development continue to add value for our customers and drive organic sales growth. We reported strong organic sales growth in the Americas & Asia region, and our Europe & Australia region reported a significant improvement in segment profit in the quarter," said Brady's President and CEO, Russell R. Shaller. "We also closed on the acquisition of Mecco at the beginning of the quarter, which is an exciting addition to our laser marking system product line. Mecco is a natural complement to our acquisition of Gravotech that we closed last year, and we're looking forward to the future through the combination of these businesses."

"We generated adjusted EPS of $1.21, which represented 8.0 percent growth compared to last year's first quarter. This improvement was driven by our organic sales growth and continued gross profit margin expansion throughout our organic businesses," said Brady's Chief Financial Officer, Ann Thornton. "We are in a net cash position of $66.8 million as of October 31, 2025, which allows us to continue to make strategic investments in both organic and inorganic opportunities to drive long-term shareholder value while returning funds to our shareholders through dividends and share buybacks."

**Fiscal 2026 Guidance:**

The Company raised the low end of its Adjusted Diluted EPS\* guidance for the year ending July 31, 2026 from $4.85 to $5.15 per share to $4.90 to $5.15 per share. The Company's GAAP earnings per diluted Class A Nonvoting Common Share guidance for the year ending July 31, 2026 was updated for acquisition-related amortization to $4.57 to $4.82 per share, from $4.55 to $4.85 per share.

The other assumptions included in our fiscal 2026 guidance include a full-year income tax rate of approximately 21 percent, depreciation and amortization expense of approximately $44 million, and capital expenditures of approximately $40 million. Our fiscal 2026 guidance is based on foreign currency exchange rates as of October 31, 2025 and assumes continued economic growth.

A webcast regarding Brady's fiscal 2026 first quarter financial results will be available at <u>www.bradycorp.com/investors</u> beginning at 9:30 a.m. central time today.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady's products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2025, employed approximately 6,400 people in its worldwide businesses. Brady's fiscal 2025 sales were approximately $1.51 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at <u>www.bradyid.com</u>.

\* Adjusted Income Before Income Taxes, Adjusted Net Income, and Adjusted Diluted EPS are non-GAAP measures. See appendix for more information on these measures, including reconciliations to the most directly comparable GAAP measures.

------

###

In this news release, statements that are not reported financial results or other historic information are "forward-looking statements." These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "project," "plan" or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of materials, labor, material shortages and supply chain disruptions, including as a result of tariffs or other impacts of the global trade environment; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady's ability to identify, integrate and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks, and systems against security breaches; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; risks associated with the loss of key employees; litigation, including product liability claims; global climate change and environmental regulations; foreign currency fluctuations; changes in tax legislation and tax rates; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the "Risk Factors" section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2025.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

------

**BRADY CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF INCOME**

**(Unaudited; Dollars in thousands, except per share data)**

---

| | | |
|:---|:---|:---|
| | Three months ended October 31, | Three months ended October 31, |
| | 2025 | 2024 |
| Net sales | $405287 | $377065 |
| Cost of goods sold | 196455 | 187376 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross margin | 208832 | 189689 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 23292 | 18921 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 117568 | 111846 |
| Total operating expenses | 140860 | 130767 |
| Operating income | 67972 | 58922 |
| Other income (expense): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment and other income | 1712 | 1234 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (1208) | (1356) |
| Income before income taxes | 68476 | 58800 |
| Income tax expense | 14540 | 12017 |
| Net income | $53936 | $46783 |
| Net income per Class A Nonvoting Common Share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.14 | $0.98 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $1.13 | $0.97 |
| Net income per Class B Voting Common Share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.13 | $0.96 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $1.11 | $0.95 |
| Weighted average common shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 47273 | 47732 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 47731 | 48217 |

---

------

**BRADY CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

**(Dollars in thousands)**

---

| | | |
|:---|:---|:---|
| | October 31, 2025 | July 31, 2025 |
| | (Unaudited) | |
| **<u>ASSETS</u>** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $182684 | $174349 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance for credit losses of $7,253 and $7,876, respectively | 248551 | 231944 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 215568 | 200881 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 15568 | 14661 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 662371 | 621835 |
| Property, plant and equipment—net | 232522 | 225572 |
| Goodwill | 681721 | 676945 |
| Other intangible assets | 114932 | 105374 |
| Deferred income taxes | 18495 | 20862 |
| Operating lease assets | 60350 | 58422 |
| Other assets | 24283 | 25243 |
| Total | $1794674 | $1734253 |
| **<u>LIABILITIES AND STOCKHOLDERS' EQUITY</u>** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $103804 | $105028 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation and benefits | 69886 | 92657 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxes, other than income taxes | 22933 | 21537 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued income taxes | 6812 | 5547 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current operating lease liabilities | 16590 | 15234 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 100683 | 90329 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 320708 | 330332 |
| Long-term debt | 115906 | 99766 |
| Long-term operating lease liabilities | 44288 | 43565 |
| Other liabilities | 68952 | 68379 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 549854 | 542042 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 43,666,121 and 43,530,012 shares, respectively | 513 | 513 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class B voting common stock—Issued and outstanding, 3,538,628 shares | 35 | 35 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 359690 | 359269 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 1360156 | 1317739 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock—7,595,366 and 7,731,475 shares, respectively, of Class A nonvoting common stock, at cost | (388847) | (393186) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (86727) | (92159) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1244820 | 1192211 |
| Total | $1794674 | $1734253 |

---

------

**BRADY CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited; Dollars in thousands)**

---

| | | |
|:---|:---|:---|
| | Three months ended October 31, | Three months ended October 31, |
| | 2025 | 2024 |
| Operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $53936 | $46783 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 11008 | 10164 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 6746 | 5813 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 3973 | (903) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 223 | (880) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (12875) | (4385) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (10980) | (2107) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | (391) | (1136) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | (19530) | (33960) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes | 1246 | 4017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 33356 | 23406 |
| Investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (10980) | (7286) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of businesses, net of cash acquired | (17416) | (140625) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 8 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (28388) | (147901) |
| Financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of dividends | (11519) | (11402) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from exercise of stock options | 5001 | 5855 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments for employee taxes withheld from stock-based awards | (3198) | (2090) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of treasury stock | (4054) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from borrowing on credit agreement | 46640 | 135149 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of borrowing on credit agreement | (30500) | (109439) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 266 | 190 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 2636 | 18263 |
| Effect of exchange rate changes on cash and cash equivalents | 731 | 1775 |
| Net increase (decrease) in cash and cash equivalents | 8335 | (104457) |
| Cash and cash equivalents, beginning of period | 174349 | 250118 |
| Cash and cash equivalents, end of period | $182684 | $145661 |

---

------

**BRADY CORPORATION AND SUBSIDIARIES**

**SEGMENT INFORMATION**

**(Unaudited; Dollars in thousands)**

---

| | | |
|:---|:---|:---|
| | Three months ended October 31, | Three months ended October 31, |
| | 2025 | 2024 |
| **NET SALES** | **NET SALES** | **NET SALES** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Americas & Asia | $268893 | $245428 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Europe & Australia | 136394 | 131637 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $405287 | $377065 |
| **SALES INFORMATION** | **SALES INFORMATION** | **SALES INFORMATION** |
| ***Americas & Asia*** | ***Americas & Asia*** | ***Americas & Asia*** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Organic | 4.7% | 5.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions | 4.9% | 7.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currency | —% | (0.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Divestiture | —% | (1.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 9.6% | 10.7% |
| ***Europe & Australia*** | ***Europe & Australia*** | ***Europe & Australia*** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Organic | (0.8)% | 0.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions | —% | 15.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currency | 4.4% | 3.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 3.6% | 19.3% |
| ***Total Company*** | ***Total Company*** | ***Total Company*** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Organic | 2.8% | 3.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions | 3.2% | 9.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currency | 1.5% | 1.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Divestiture | —% | (1.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 7.5% | 13.6% |
| **SEGMENT PROFIT** | **SEGMENT PROFIT** | **SEGMENT PROFIT** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Americas & Asia | $59863 | $54900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Europe & Australia | 18732 | 13114 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total segment profit | $78595 | $68014 |
| **SEGMENT PROFIT AS A PERCENT OF NET SALES** | **SEGMENT PROFIT AS A PERCENT OF NET SALES** | **SEGMENT PROFIT AS A PERCENT OF NET SALES** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Americas & Asia | 22.3% | 22.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Europe & Australia | 13.7% | 10.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 19.4% | 18.0% |

---

---

| | | |
|:---|:---|:---|
| | Three months ended October 31, | Three months ended October 31, |
| | 2025 | 2024 |
| Total segment profit | $78595 | $68014 |
| Unallocated amounts: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administrative costs | (10623) | (9092) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment and other income | 1712 | 1234 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (1208) | (1356) |
| Income before income taxes | $68476 | $58800 |

---

------

**GAAP to NON-GAAP MEASURES**

(Unaudited; Dollars in Thousands, Except Per Share Amounts)

In accordance with the U.S. Securities and Exchange Commission's Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.

**Adjusted Income Before Income Taxes:**

Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes:

---

| | | |
|:---|:---|:---|
| | Three months ended October 31, | Three months ended October 31, |
| | 2025 | 2024 |
| **Income before income taxes (GAAP measure)** | $68476 | $58800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 5341 | 4713 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-recurring acquisition-related costs and other expenses |  | 5059 |
| **Adjusted Income Before Income Taxes (non-GAAP measure)** | $**73817** | $**68572** |

---

**Adjusted Income Tax Expense:**

Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense:

---

| | | |
|:---|:---|:---|
| | Three months ended October 31, | Three months ended October 31, |
| | 2025 | 2024 |
| **Income tax expense (GAAP measure)** | $14540 | $12017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 1289 | 1133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-recurring acquisition-related costs and other expenses |  | 1265 |
| **Adjusted Income Tax Expense (non-GAAP measure)** | $**15829** | $**14415** |

---

**Adjusted Net Income:**

Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income:

---

| | | |
|:---|:---|:---|
| | Three months ended October 31, | Three months ended October 31, |
| | 2025 | 2024 |
| **Net income (GAAP measure)** | $53936 | $46783 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 4052 | 3580 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-recurring acquisition-related costs and other expenses |  | 3794 |
| **Adjusted Net Income (non-GAAP measure)** | $**57988** | $**54157** |

---

------

**Adjusted Diluted EPS:**

Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding):

---

| | | |
|:---|:---|:---|
| | Three months ended October 31, | Three months ended October 31, |
| | 2025 | 2024 |
| **Net income per Class A Nonvoting Common Share (GAAP measure)** | $1.13 | $0.97 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 0.08 | 0.07 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-recurring acquisition-related costs and other expenses |  | 0.08 |
| **Adjusted Diluted EPS (non-GAAP measure)** | $**1.21** | $**1.12** |

---

**Adjusted Diluted EPS Guidance:**

---

| | | |
|:---|:---|:---|
| | Fiscal 2026 Expectations | Fiscal 2026 Expectations |
| | Low | High |
| **Earnings per Class A Nonvoting Common Share (GAAP measure)** | $4.57 | $4.82 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 0.33 | 0.33 |
| **Adjusted Diluted EPS (non-GAAP measure)** | $**4.90** | $**5.15** |

---

## Exhibit 99.2

![](f26q1conferencecallprese001.jpg)

F'26 Q1 Financial Results Brady Corporation November 17, 2025

------

![](f26q1conferencecallprese002.jpg)

Forward-Looking Statements In this news release, statements that are not reported financial results or other historic information are "forward-looking statements." These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations. The use of words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "project," "plan" or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of materials, labor, material shortages and supply chain disruptions, including as a result of tariffs or other impacts of the global trade environment; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady's ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks and systems against security breaches; extensive regulations by U.S. and non-U.S. governmental and self- regulatory entities; risks associated with the loss of key employees; litigation, including product liability claims; global climate change and environmental regulations; foreign currency fluctuations; changes in tax legislation and tax rates; potential write- offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the "Risk Factors" section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2025. These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward- looking statements. Brady does not undertake to update its forward-looking statements except as required by law. 2

------

![](f26q1conferencecallprese003.jpg)

Q1 F'26 Highlights 3 \* Adjusted Diluted Earnings per Share is a non-GAAP measure. See appendix. Organic sales growth of 2.8%. Americas & Asia organic sales growth of 4.7%. Europe & Australia organic sales decline of 0.8%. Acquisition growth of 3.2%. Sales Growth GPM of 51.5% compared to 50.3% in Q1 of F'25. Gross profit in Q1 last year included purchase accounting adjustments related to the acquisition of Gravotech. Gross Profit Margin GAAP EPS of $1.13 in Q1 of F'26 vs. $0.97 in Q1 of F'25. Adjusted Diluted Earnings per Share\* increased 8.0% to $1.21 in Q1 of F'26 compared to $1.12 in Q1 of F'25. Growth in Adjusted Diluted Earnings per Share\* Paid dividends of $11.5M. Purchased 55,010 shares in Q1 of F'26 for $4.1M. In a net cash position of $66.8M at October 31, 2025. Returning Capital to our Shareholders

------

![](f26q1conferencecallprese004.jpg)

Sales Overview 4 Q1 F'26 SALES: Total sales increased 7.5%. Organic sales increased 2.8%. • Americas & Asia – Organic sales increased 4.7%. • Europe & Australia – Organic sales declined 0.8%. Foreign currency translation increased sales 1.5%. Acquisitions increased sales 3.2%. $323 $326 $337 $346 $332 $323 $343 $343 $377 $357 $383 $397 $405 $225 $250 $275 $300 $325 $350 $375 $400 $425 Q1 F'23 6.9% Q2 F'23 6.3% Q3 F'23 1.9% Q4 F'23 6.9% Q1 F'24 2.7% Q2 F'24 1.6% Q3 F'24 4.5% Q4 F'24 1.6% Q1 F'25 3.6% Q2 F'25 2.6% Q3 F'25 1.6% Q4 F'25 2.4% Q1 F'26 2.8%Organic Growth SALES (millions of USD) Q1 F'26 SALES COMMENTARY: Organic sales grew 3.7% in the Americas with growth in wire ID and product ID. Asia organic sales grew 11.9% with growth throughout the region. Organic sales declined 0.9% in Europe and increased 0.3% in Australia.

------

![](f26q1conferencecallprese005.jpg)

Gross Profit Margin 5 $155 $156 $170 $176 $172 $162 $177 $177 $190 $176 $195 $200 $209 48.1% 48.0% 50.3% 50.8% 51.7% 50.2% 51.6% 51.6% 50.3% 49.3% 51.0% 50.4% 51.5% 40% 42% 44% 46% 48% 50% 52% $100 $125 $150 $175 $200 $225 $250 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 Q4 F'25 Q1 F'26 GROSS PROFIT & GPM% (millions of USD) Q1 F'26 – GROSS PROFIT MARGIN: Gross profit margin of 51.5% compared to 50.3% in Q1 of F'25. The non-recurring impact of purchase accounting charges related to the acquisition of Gravotech reduced gross profit margin by approximately 110 basis points in Q1 of F'25.

------

![](f26q1conferencecallprese006.jpg)

SG&A Expense 6 Q1 F'26 – SG&A EXPENSE: SG&A expense decreased as a percent of sales when compared to Q1 last year primarily due to cost reduction actions taken in fiscal year 2025. We continue to focus on identifying and executing sustainable efficiency gains in order to offset cost increases, while making the necessary investments to drive future sales growth. $90 $92 $91 $97 $96 $91 $96 $93 $112 $106 $109 $118 $118 27.9% 28.3% 27.0% 28.2% 29.0% 28.3% 27.9% 27.2% 29.7% 29.7% 28.4% 29.7% 29.0% 22% 24% 26% 28% 30% 32% $75 $90 $105 $120 $135 $150 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 Q4 F'25 Q1 F'26 SG&A EXPENSE AND SG&A EXPENSE AS A % OF SALES (millions of USD)

------

![](f26q1conferencecallprese007.jpg)

R&D Expense 7 Q1 F'26 – R&D EXPENSE: Investments in R&D continue to drive organic sales growth; F'25 acquisitions have a higher level of R&D as a percentage of sales. $13.9 $15.4 $15.7 $16.3 $15.7 $16.8 $17.7 $17.5 $18.9 $18.7 $19.2 $23.1 $23.3 4.3% 4.7% 4.7% 4.7% 4.7% 5.2% 5.1% 5.1% 5.0% 5.2% 5.0% 5.8% 5.7% 2.0% 3.0% 4.0% 5.0% 6.0% $10.0 $14.0 $18.0 $22.0 $26.0 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 Q4 F'25 Q1 F'26 R&D EXPENSE AND R&D EXPENSE AS A % OF SALES (millions of USD)

------

![](f26q1conferencecallprese008.jpg)

Income Before Income Taxes 8 $50.3 $48.5 $63.0 $63.8 $59.4 $55.8 $64.4 $68.2 $58.8 $52.0 $65.7 $60.5 $68.5 $10 $20 $30 $40 $50 $60 $70 Q1 F'23 12.6% Q2 F'23 15.4% Q3 F'23 23.0% Q4 F'23 18.2% Q1 F'24 18.0% Q2 F'24 15.1% Q3 F'24 2.2% Q4 F'24 6.9% Q1 F'25 (1.0%) Q2 F'25 (6.8%) Q3 F'25 2.1% Q4 F'25 (11.3%) Q1 F'26 16.5% \* Adjusted Income Before Income Taxes is a non-GAAP measure. See appendix. (millions of USD)INCOME BEFORE INCOME TAXES (GAAP) Q1 F'26 – INCOME BEFORE INCOME TAXES: GAAP Income before income taxes increased 16.5% to $68.5M in Q1 of F'26 compared to $58.8M in Q1 of F'25. Adjusted Income Before Income Taxes\* increased 7.6% to $73.8M in Q1 of F'26 compared to $68.6M in Q1 of F'25. Year-on-Year Growth (Decline)

------

![](f26q1conferencecallprese009.jpg)

Net Income & Diluted EPS 9 Q1 F'26 – NET INCOME & DILUTED EPS: GAAP Net Income was $53.9M in Q1 of F'26 compared to $46.8M in Q1 of F'25. • Adjusted Net Income\* was $58.0M in Q1 of F'26 compared to $54.2M in Q1 of F'25 (increased 7.1%). GAAP Diluted EPS was $1.13 in Q1 of F'26 compared to $0.97 in Q1 of F'25. • Adjusted Diluted EPS\* was $1.21 in Q1 of F'26 compared to $1.12 in Q1 of F'25 (increased 8.0%). \* Adjusted Net Income and Adjusted Diluted EPS are non-GAAP measures. See appendix. $39.4 $38.0 $48.1 $49.4 $47.2 $43.6 $50.9 $55.5 $46.8 $40.3 $52.3 $49.9 $53.9 $20 $30 $40 $50 $60 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 Q4 F'25 Q1 F'26 NET INCOME (GAAP) (millions of USD) $0.79 $0.76 $0.96 $1.00 $0.97 $0.90 $1.05 $1.15 $0.97 $0.83 $1.09 $1.04 $1.13 $0.40 $0.60 $0.80 $1.00 $1.20 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 Q4 F'25 Q1 F'26 DILUTED EPS (GAAP)

------

![](f26q1conferencecallprese010.jpg)

Cash Generation 10 CASH FLOW FROM OPERATING ACTIVITIES $28.0 $29.4 $72.5 $79.3 $62.3 $36.1 $72.7 $84.0 $23.4 $39.6 $59.9 $58.3 $33.4 -$5 $20 $45 $70 $95 Q1 F'23 71% Q2 F'23 77% Q3 F'23 151% Q4 F'23 161% Q1 F'24 132% Q2 F'24 83% Q3 F'24 143% Q4 F'24 151% Q1 F'25 50% Q2 F'25 98% Q3 F'25 115% Q4 F'25 117% Q1 F'26 62%% of Net Income CASH FLOWS IN Q1 OF F'26: Overview: Cash flow from operating activities was $33.4M in Q1 of F'26 vs. $23.4M in Q1 of F'25. Free cash flow\* was $22.4M in Q1 of F'26 compared to $16.1M in Q1 of F'25. Returning Funds to our Shareholders: In Q1 of F'26, we returned a total of $15.6M to our shareholders in the form of dividends and share buybacks. Dividends – Increased our annual dividend for the 40th consecutive year. Share Buybacks – Repurchased 55k shares in Q1 of F'26 for $4.1M (average price of $73.69/share). \* Free cash flow is calculated as Net Cash Provided by Operating Activities less Capital Expenditures. (millions of USD) (millions of USD) 3 Mos. Ended Oct. 31, 2025 3 Mos. Ended Oct. 31, 2024 Cash Balance - Beginning of Period 174.3$250.1$ Cash Flow from Operating Activities 33.4 23.4 Capital Expenditures (11.0) (7.3) Dividends (11.5) (11.4) Share Repurchases (4.1) - Business Acquisitions (17.4) (140.6) Debt Borrowings 16.1 25.7 Effect of Exchange Rates on Cash 0.7 1.8 Other 2.2 4.0 Cash Balance - End of Period 182.7$145.7$

------

![](f26q1conferencecallprese011.jpg)

Net Cash 11 STRONG BALANCE SHEET: October 31, 2025 cash = $182.7M. October 31, 2025 debt = $115.9M. Balance sheet provides flexibility for future organic investments and strategic M&A. $15 $31 $84 $102 $123 $96 $97 $159 $29 $51 $49 $75 $67 $0 $50 $100 $150 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 Q3 F'25 Q4 F'25 Q1 F'26 NET CASH (millions of USD)

------

![](f26q1conferencecallprese012.jpg)

F'26 Updated Diluted EPS Guidance GAAP Diluted EPS $4.57 to $4.82 (+16.0% to +22.3% vs. F'25) F'26 Adjusted Diluted EPS\* $4.90 to $5.15 (+6.5% to +12.0% vs. F'25) Guidance Assumptions: Organic sales growth in the low-single digit percentages. Full-year income tax rate of approximately 21%. Foreign currency exchange rates as of October 31, 2025. Depreciation and amortization expense of approximately $44M. Capital expenditures of approximately $40M. 12 \* Adjusted Diluted EPS is a non-GAAP measure. See appendix.

------

![](f26q1conferencecallprese013.jpg)

Americas & Asia 13 • Revenues increased 9.6% in Q1 of F'26: • Organic growth = + 4.7%. • Acquisition = + 4.9%. • Organic sales grew 3.7% in the Americas with growth in wire ID and product ID. • Organic sales grew 11.9% in Asia with growth throughout the region. • Growth in segment profit due to organic sales growth in higher gross margin product lines. Q1 of F'25 segment profit included acquisition-related costs and purchase accounting adjustments. Q1 F'26 SUMMARY:Q1 F'26 vs. Q1 F'25 (millions of USD) $222 $212 $225 $228 $245 $234 $254 $261 $269 23% 21% 22% 23% 22% 20% 23% 20% 22% 0% 5% 10% 15% 20% 25% $100 $150 $200 $250 $300 $350 Q1 F'24 3.3% - (1.9%) Q2 F'24 1.2% 0.1% (5.1%) Q3 F'24 4.5% (0.1%) (3.5%) Q4 F'24 3.4% (0.8%) (2.2%) Q1 F'25 5.1% (0.2%) 5.8% Q2 F'25 4.3% (1.4%) 7.6% Q3 F'25 5.4% (1.1%) 8.6% Q4 F'25 4.3% - 9.8% Q1 F'26 4.7% - 4.9% SALES & SEGMENT PROFIT % (millions of USD) Q1 F'26 Q1 F'25 Change Sales $268.9 $245.4 + 9.6% Segment Profit 59.9 54.9 + 9.0% Segment Profit % 22.3% 22.4% - 10 bps • Mid-single digit organic sales growth in F'26. • Growth in segment profit excluding amortization. OUTLOOK: Organic For. Curr. Acq. & Div.

------

![](f26q1conferencecallprese014.jpg)

Europe & Australia 14 • Revenues increased 3.6% in Q1 of F'26: • Organic decline = (0.8%). • Fx increase = + 4.4%. • Organic sales declined 0.9% in Europe and grew 0.3% in Australia. • Segment profit increased due to cost reduction actions from fiscal year 2025. Q1 of F'25 segment profit included acquisition-related costs and purchase accounting adjustments. Q1 F'26 SUMMARY:Q1 F'26 vs. Q1 F'25 (millions of USD) $110 $111 $119 $115 $132 $123 $129 $136 $136 15% 14% 16% 17% 10% 9% 14% 11% 14% 0% 5% 10% 15% 20% $50 $100 $150 $200 $250 Q1 F'24 1.4% 4.6% - Q2 F'24 2.5% 2.0% - Q3 F'24 4.4% (0.6%) - Q4 F'24 (1.8%) (1.2%) - Q1 F'25 0.7% 3.6% 15.0% Q2 F'25 (0.8%) (3.6%) 15.1% Q3 F'25 (5.4%) (0.1%) 14.2% Q4 F'25 (1.3%) 5.7% 14.4% Q1 F'26 (0.8%) 4.4% - SALES & SEGMENT PROFIT % Q1 F'26 Q1 F'25 Change Sales $136.4 $131.6 + 3.6% Segment Profit 18.7 13.1 + 42.8% Segment Profit % 13.7% 10.0% + 370 bps Organic For. Curr. Acquisitions • Low-single digit organic sales growth in F'26. • Growth in segment profit excluding amortization. OUTLOOK: (millions of USD)

------

![](f26q1conferencecallprese015.jpg)

Investor Relations Brady Contact: Ann Thornton Investor Relations 414-438-6887 Ann_Thornton@bradycorp.com See our website at www.bradycorp.com/investors 15

------

![](f26q1conferencecallprese016.jpg)

Appendix GAAP to Non-GAAP Reconciliations

------

![](f26q1conferencecallprese017.jpg)

Non-GAAP Reconciliations 17 2025 2024 68,476$58,800$ Amortization expense 5,341 4,713 Non-recurring acquisition-related costs and other expenses - 5,059 73,817$68,572$2025 2024 14,540$12,017$ Amortization expense 1,289 1,133 Non-recurring acquisition-related costs and other expenses - 1,265 15,829$14,415$ GAAP to NON-GAAP MEASURES Adjusted Income Before Income Taxes: (Unaudited; Dollars in Thousands, Except Per Share Amounts) Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes: Three months ended October 31, Income before income taxes (GAAP measure) In accordance with the U.S. Securities and Exchange Commission's Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Adjusted Income Tax Expense (non-GAAP measure) Adjusted Income Before Income Taxes (non-GAAP measure) Income tax expense (GAAP measure) Adjusted Income Tax Expense: Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense: Three months ended October 31,

------

![](f26q1conferencecallprese018.jpg)

Non-GAAP Reconciliations 18 2025 2024 53,936$46,783$ Amortization expense 4,052 3,580 Non-recurring acquisition-related costs and other expenses - 3,794 57,988$54,157$2025 2024 $1.13 $0.97 Amortization expense 0.08 0.07 Non-recurring acquisition-related costs and other expenses - 0.08 1.21$1.12$ Diluted EPS Excluding Certain Items Guidance: Low High Earnings per diluted Class A Common Share (GAAP measure) $4.57 $4.82 Amortization expense 0.33 0.33 Adjusted Diluted EPS (non-GAAP measure) 4.90$5.15$ Fiscal 2026 Expectations Adjusted Diluted EPS (non-GAAP measure) Adjusted Net Income (non-GAAP measure) Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income: Net income (GAAP measure) Adjusted Diluted EPS: Three months ended October 31, Net income per Class A Nonvoting Common Share (GAAP measure) Three months ended October 31, Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding): GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) Adjusted Net Income: In accordance with the U.S. Securities and Exchange Commission's Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.

------